Gambia Children Deaths: WHO has issued a medical product alert on 4 Cough and Cold Syrups made by Maiden Pharmaceuticals, India. The WHO has potentially linked it to kidney injuries and the deaths of 66 children in The Gambia. Reuters quoted the WHO as saying that further investigation is being done with the company and regulatory authorities.
“Laboratory analysis of samples from each of the four products confirms that they contain unacceptable amounts of diethylene glycol and ethylene glycol,” the WHO said in a medical product alert. WHO Director-General Dr. Tedros Adhanom Ghebreyesus said that the WHO today issued a medical product alert for four contaminated drugs identified in The Gambia as potentially linked to serious kidney injuries and 66 deaths in children. The death of these children is a great shock to their families.
“The four medicines are cough and cold syrups produced by Maiden Pharmaceuticals Limited, in India. WHO is conducting further investigation with the company and regulatory authorities in India”-@DrTedros https://t.co/PceTWc836t
— World Health Organization (WHO) (@WHO) October 5, 2022
Alert to other countries
He further added that the four medicines are cough and cold syrups produced by Maiden Pharmaceuticals Ltd in India. WHO is conducting further investigation with the company concerned and regulatory authorities in India. Contaminated products have so far only been detected in The Gambia, they may have been distributed to other countries. WHO recommends detection and removal of these products to prevent further harm to patients in all countries.
read this also-